BACKGROUND: The measurement of triglyceride (TG)-rich particles after an oral fat challenge has been used to provide a measure of risk for coronary artery disease independent of the fasting plasma triglyceride concentration. The analytical "gold standard" for measuring TG-rich lipoproteins uses density gradient ultracentrifugation; however, this technique is labor-intensive. Because of our need to perform numerous postprandial analyses of TG-rich lipoproteins for a large interventional study (Genetics of Lipid Lowering Drugs and Diet Network), we evaluated the use of nuclear magnetic resonance (NMR) spectroscopy for measuring TG-rich particles. METHODS: EDTA-blood samples were obtained 0, 3.5, 6, and 8 h after ingestion of an oral fat meal (89% of calories from fat) in 20 apparently healthy individuals. The plasma TG concentrations of chylomicron and chylomicron remnant/VLDL fractions were analyzed by ultracentrifugation and NMR spectroscopy. RESULTS: Comparison of all values (n = 78) by ultracentrifugation (x) and NMR (y) produced a linear regression equation of y = 0.979x - 0.035 mmol/L (R(2) = 0.90) for chylomicrons and y = 1.398x + 0.067 mmol/L (R(2) = 0.96) for the fraction containing chylomicron remnants and VLDL. Postprandial response of chylomicrons and chylomicron remnant/VLDL was similar, with maximum response occurring between 3.5 to 6 h regardless of method of measurement. CONCLUSION: Chylomicron and chylomicron remnant/VLDL fraction measurements obtained by NMR have a high degree of correlation with results produced by ultracentrifugation. NMR may therefore be suitable as an alternative method for the measurement of postprandial TG-rich lipoproteins in individuals consuming a high-fat meal.
BACKGROUND: The measurement of triglyceride (TG)-rich particles after an oral fat challenge has been used to provide a measure of risk for coronary artery disease independent of the fasting plasma triglyceride concentration. The analytical "gold standard" for measuring TG-rich lipoproteins uses density gradient ultracentrifugation; however, this technique is labor-intensive. Because of our need to perform numerous postprandial analyses of TG-rich lipoproteins for a large interventional study (Genetics of Lipid Lowering Drugs and Diet Network), we evaluated the use of nuclear magnetic resonance (NMR) spectroscopy for measuring TG-rich particles. METHODS:EDTA-blood samples were obtained 0, 3.5, 6, and 8 h after ingestion of an oral fat meal (89% of calories from fat) in 20 apparently healthy individuals. The plasma TG concentrations of chylomicron and chylomicron remnant/VLDL fractions were analyzed by ultracentrifugation and NMR spectroscopy. RESULTS: Comparison of all values (n = 78) by ultracentrifugation (x) and NMR (y) produced a linear regression equation of y = 0.979x - 0.035 mmol/L (R(2) = 0.90) for chylomicrons and y = 1.398x + 0.067 mmol/L (R(2) = 0.96) for the fraction containing chylomicron remnants and VLDL. Postprandial response of chylomicrons and chylomicron remnant/VLDL was similar, with maximum response occurring between 3.5 to 6 h regardless of method of measurement. CONCLUSION: Chylomicron and chylomicron remnant/VLDL fraction measurements obtained by NMR have a high degree of correlation with results produced by ultracentrifugation. NMR may therefore be suitable as an alternative method for the measurement of postprandial TG-rich lipoproteins in individuals consuming a high-fat meal.
Authors: Alexis C Frazier-Wood; Stella Aslibekyan; Devin M Absher; Paul N Hopkins; Jin Sha; Michael Y Tsai; Hemant K Tiwari; Lindsay L Waite; Degui Zhi; Donna K Arnett Journal: J Lipid Res Date: 2014-04-07 Impact factor: 5.922
Authors: Daruneewan Warodomwichit; Donna K Arnett; Edmond K Kabagambe; Michael Y Tsai; James E Hixson; Robert J Straka; Michael Province; Ping An; Chao-Qiang Lai; Ingrid Borecki; Jose M Ordovas Journal: J Nutr Date: 2009-01-13 Impact factor: 4.798
Authors: Ying Zhang; Alicia J Jenkins; Arpita Basu; Julie A Stoner; Maria F Lopes-Virella; Richard L Klein; Timothy J Lyons Journal: J Lipid Res Date: 2015-12-09 Impact factor: 5.922
Authors: Pablo Perez-Martinez; Dolores Corella; Jian Shen; Donna K Arnett; Nikos Yiannakouris; E Syong Tai; Marju Orho-Melander; Katherine L Tucker; Michael Tsai; Robert J Straka; Michael Province; Chew Suok Kai; Francisco Perez-Jimenez; Chao-Qiang Lai; Jose Lopez-Miranda; Marisa Guillen; Laurence D Parnell; Ingrid Borecki; Sekar Kathiresan; Jose M Ordovas Journal: Am J Clin Nutr Date: 2008-12-03 Impact factor: 7.045
Authors: A C Frazier-Wood; E K Kabagambe; M K Wojczynski; I B Borecki; H K Tiwari; C E Smith; J M Ordovas; D K Arnett Journal: Nutr Metab Cardiovasc Dis Date: 2013-02-26 Impact factor: 4.222
Authors: Jennifer A Smith; Donna K Arnett; Reagan J Kelly; Jose M Ordovas; Yan V Sun; Paul N Hopkins; James E Hixson; Robert J Straka; James M Peacock; Sharon L R Kardia Journal: Eur J Hum Genet Date: 2008-01-23 Impact factor: 4.246
Authors: Mireia Junyent; Donna K Arnett; Michael Y Tsai; Edmond K Kabagambe; Robert J Straka; Michael Province; Ping An; Chao-Qiang Lai; Laurence D Parnell; Jian Shen; Yu-Chi Lee; Ingrid Borecki; Jose M Ordovás Journal: J Nutr Date: 2009-03-25 Impact factor: 4.798
Authors: Alexis C Frazier-Wood; Ingrid B Borecki; Mary F Feitosa; Paul N Hopkins; Caren E Smith; Donna K Arnett Journal: Int J Sport Nutr Exerc Metab Date: 2013-08-26 Impact factor: 4.599
Authors: Daniel I Chasman; Guillaume Paré; Samia Mora; Jemma C Hopewell; Gina Peloso; Robert Clarke; L Adrienne Cupples; Anders Hamsten; Sekar Kathiresan; Anders Mälarstig; José M Ordovas; Samuli Ripatti; Alex N Parker; Joseph P Miletich; Paul M Ridker Journal: PLoS Genet Date: 2009-11-20 Impact factor: 5.917